We have gotten very comfortable asking one question about almost everything: What is the return on investment? In business, that is usually a reasonable question. In medical research, it can become a limiting one. Some of the most important scientific work does not begin with a product, a treatment, or a clear path to revenue. It begins with a question about how something works, why a biological process behaves the way it does, or what researchers still do not understa

But what they don’t see is the grind behind the scenes. The years of effort, the research that doesn’t get funded, and the scientists struggling to keep momentum without institutional support.

If you want to slow progress down, wrap it in red tape. That’s the reality for far too much medical research in this country. Scientists with bold ideas spend more time formatting grant proposals than actually running experiments. And when the funding does come through, it’s often a year too late, tied up in approval cycles, institutional requirements, and layers of administrative overhead. The worst part? Some of the most promising ideas never even get submitted. They’re too